Edwards

Looking for a compelling reason to buy shares of Edwards Lifesciences Corp (NYSE: EW)? Here are three reasons, courtesy of Search Results Canaccord Genuity's Jason Mills. Shares of Edwards were trading higher by nearly 9 percent on Wednesday and hit an intra-morning high of $113.04 following the...

The market's bullish response to Neovasc Inc (US) (NASDAQ: NVCN)'s announcement that Boston Scientific Corporation (NYSE: BSX) was set to buy a 15 percent stake in the company was bolstered by a positive data release on Neovasc's Tiara mitral valve. Shares gained 70 percent over the trading day...